10:00 AM onwards
Le Meridien, Hyderabad
About the Event
Injectables have quietly become the engine behind India’s next pharma growth story. Once a niche within formulations, they are now among the fastest-expanding segments, driven by demand for safer, faster and more effective therapies. According to IMARC Group, India’s generic injectables market is projected to reach $7.6 billion by 2033, growing at a CAGR of 10.28 per cent.
Yet this growth story comes with real challenges like heightened regulatory scrutiny from global agencies, heavy dependence on imported APIs, and capability gaps in areas such as biosimilars, oncology injectables and advanced formulations.
Express Pharma’s second edition of the Injectable Innovations Conclave 2026 is designed to be a catalyst for the next leap of growth in this segment. Under the theme, ‘The new frontiers in injectable excellence,’ it will bring together leaders from R&D, sterile operations, packaging, supply chain and technology, to strengthen India’s injectable ecosystem. It will enable and empower the players to compete on innovation, quality and reliability, not just scale.
Topics to be discussed
To lead the next era of injectables, the industry must integrate sterility, science, packaging innovation, automation and quality into one powerful ecosystem. Join the Injectable Innovations Conclave 2026 and be a part of shaping this future
Sterility & Compliance 2026
What global regulators expect today
GLP-1 & biologics
Is India ready for high-demand injectables?
Beyond generics
Moving into complex injectables, oncology and biosimilars
Injectable supply chain
Fixing API dependence, building resilience
Packaging Intelligence
Smarter systems for safer injectables
Automation & AI
Transforming sterile manufacturing workflows
India as an injectable hub
Growing CDMO strength and global partnership
Meet leaders at the conclave
Injectables development
R&D Formulation
Technology Transfer
Extractables & Leachables
R&D Packaging
Sterilisation
Drug Delivery
Quality
Regulatory Affairs
Why Attend
Gain access to the latest trends, technologies, and business strategies shaping India's generic injectables market
Connect with industry leaders, decision-makers, and professionals
Acquire in-depth knowledge of the market dynamics, competitor landscapes, and regulatory changes
Stay informed about the latest government policies and regulatory frameworks impacting the pharma industry
Explore advancements in drug delivery systems, including self-injection devices and more
Learn about successful market entry and expansion strategies to capitalise on new opportunities within India's generic injectables market
Participate in collaborative discussions to share experiences and learn from industry peers
Speakers
Dr Ravikumar N
President – Formulations R&D, MSN Laboratories
Dr Tathagata Dutta
President, Jodas Expoim
Mr Shaunak J Dave
CEO & MD, Antares Vision Group | India
Partners
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
